Third Rock Ventures II, L.P. Insider Trading $JNCE Jounce Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Third Rock Ventures II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).
Third Rock Ventures II, L.P. in Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 4,447,829 shares
Current Value: $76,947,442
Latest Transaction: Jun 14 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Third Rock Ventures II, L.P. in Jounce Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 4,447,829 | 5.9 M to 4.4 M (-25.22 %) |
| Mar 15 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,250,000 | 0 | 6,500,349 | 7.8 M to 6.5 M (-16.13 %) |
| Nov 19 2020 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 7.25 | 15,000 | 108,773 | 9,215,349 | 9.2 M to 9.2 M (-0.16 %) |
| Nov 13 2020 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 9,230,349 | 10.2 M to 9.2 M (-9.77 %) |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,250,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 35,750,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 3,048,780 | 0 | 3,048,780 | 0 to 3 M |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 9,688,344 | 0 | 10,230,349 | 542 K to 10.2 M (+1,787.50 %) |
Page: 1